| Product Code: ETC6665031 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Premenstrual Dysphoric Disorder Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Premenstrual Dysphoric Disorder Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Premenstrual Dysphoric Disorder Market - Industry Life Cycle |
3.4 Canada Premenstrual Dysphoric Disorder Market - Porter's Five Forces |
3.5 Canada Premenstrual Dysphoric Disorder Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 Canada Premenstrual Dysphoric Disorder Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 Canada Premenstrual Dysphoric Disorder Market Revenues & Volume Share, By Symptoms, 2021 & 2031F |
3.8 Canada Premenstrual Dysphoric Disorder Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
3.9 Canada Premenstrual Dysphoric Disorder Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 Canada Premenstrual Dysphoric Disorder Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.11 Canada Premenstrual Dysphoric Disorder Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Canada Premenstrual Dysphoric Disorder Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and recognition of premenstrual dysphoric disorder (PMDD) in Canada |
4.2.2 Growing demand for effective treatments for PMDD symptoms |
4.2.3 Rising prevalence of PMDD among women in Canada |
4.3 Market Restraints |
4.3.1 Limited availability and access to specialized healthcare services for PMDD |
4.3.2 High cost associated with existing PMDD treatments |
4.3.3 Social stigma and lack of understanding surrounding PMDD |
5 Canada Premenstrual Dysphoric Disorder Market Trends |
6 Canada Premenstrual Dysphoric Disorder Market, By Types |
6.1 Canada Premenstrual Dysphoric Disorder Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 Canada Premenstrual Dysphoric Disorder Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 Canada Premenstrual Dysphoric Disorder Market Revenues & Volume, By Antidepressants, 2021- 2031F |
6.1.4 Canada Premenstrual Dysphoric Disorder Market Revenues & Volume, By Nonsteroidal Anti-inflammatory Drugs (NSAIDs), 2021- 2031F |
6.1.5 Canada Premenstrual Dysphoric Disorder Market Revenues & Volume, By Analgesics, 2021- 2031F |
6.1.6 Canada Premenstrual Dysphoric Disorder Market Revenues & Volume, By Hormone Therapy, 2021- 2031F |
6.1.7 Canada Premenstrual Dysphoric Disorder Market Revenues & Volume, By Exercise, 2021- 2031F |
6.1.8 Canada Premenstrual Dysphoric Disorder Market Revenues & Volume, By Diet, 2021- 2031F |
6.2 Canada Premenstrual Dysphoric Disorder Market, By Diagnosis |
6.2.1 Overview and Analysis |
6.2.2 Canada Premenstrual Dysphoric Disorder Market Revenues & Volume, By Physical Examination, 2021- 2031F |
6.2.3 Canada Premenstrual Dysphoric Disorder Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Canada Premenstrual Dysphoric Disorder Market, By Symptoms |
6.3.1 Overview and Analysis |
6.3.2 Canada Premenstrual Dysphoric Disorder Market Revenues & Volume, By Depression, 2021- 2031F |
6.3.3 Canada Premenstrual Dysphoric Disorder Market Revenues & Volume, By Intense Anger, 2021- 2031F |
6.3.4 Canada Premenstrual Dysphoric Disorder Market Revenues & Volume, By Mood Swings, 2021- 2031F |
6.3.5 Canada Premenstrual Dysphoric Disorder Market Revenues & Volume, By Irritability, 2021- 2031F |
6.3.6 Canada Premenstrual Dysphoric Disorder Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Canada Premenstrual Dysphoric Disorder Market, By Dosage |
6.4.1 Overview and Analysis |
6.4.2 Canada Premenstrual Dysphoric Disorder Market Revenues & Volume, By Tablet, 2021- 2031F |
6.4.3 Canada Premenstrual Dysphoric Disorder Market Revenues & Volume, By Injection, 2021- 2031F |
6.4.4 Canada Premenstrual Dysphoric Disorder Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Canada Premenstrual Dysphoric Disorder Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 Canada Premenstrual Dysphoric Disorder Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.3 Canada Premenstrual Dysphoric Disorder Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.5.4 Canada Premenstrual Dysphoric Disorder Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Canada Premenstrual Dysphoric Disorder Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 Canada Premenstrual Dysphoric Disorder Market Revenues & Volume, By Clinic, 2021- 2031F |
6.6.3 Canada Premenstrual Dysphoric Disorder Market Revenues & Volume, By Hospital, 2021- 2031F |
6.6.4 Canada Premenstrual Dysphoric Disorder Market Revenues & Volume, By Others, 2021- 2031F |
6.7 Canada Premenstrual Dysphoric Disorder Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 Canada Premenstrual Dysphoric Disorder Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.7.3 Canada Premenstrual Dysphoric Disorder Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.7.4 Canada Premenstrual Dysphoric Disorder Market Revenues & Volume, By , 2021- 2031F |
7 Canada Premenstrual Dysphoric Disorder Market Import-Export Trade Statistics |
7.1 Canada Premenstrual Dysphoric Disorder Market Export to Major Countries |
7.2 Canada Premenstrual Dysphoric Disorder Market Imports from Major Countries |
8 Canada Premenstrual Dysphoric Disorder Market Key Performance Indicators |
8.1 Number of healthcare providers specializing in PMDD treatment |
8.2 Percentage of women diagnosed with PMDD seeking treatment |
8.3 Average time from diagnosis to treatment initiation |
9 Canada Premenstrual Dysphoric Disorder Market - Opportunity Assessment |
9.1 Canada Premenstrual Dysphoric Disorder Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 Canada Premenstrual Dysphoric Disorder Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.3 Canada Premenstrual Dysphoric Disorder Market Opportunity Assessment, By Symptoms, 2021 & 2031F |
9.4 Canada Premenstrual Dysphoric Disorder Market Opportunity Assessment, By Dosage, 2021 & 2031F |
9.5 Canada Premenstrual Dysphoric Disorder Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 Canada Premenstrual Dysphoric Disorder Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.7 Canada Premenstrual Dysphoric Disorder Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Canada Premenstrual Dysphoric Disorder Market - Competitive Landscape |
10.1 Canada Premenstrual Dysphoric Disorder Market Revenue Share, By Companies, 2024 |
10.2 Canada Premenstrual Dysphoric Disorder Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here